![Hans Arwidsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans Arwidsson
Directeur/Membre du Conseil chez
Eurocince Securities AB
Profil
Dr. Hans Arwidsson is a Deputy Director at Ingrid Gjellan Fastighetsförmedling AB. He is on the Board of Directors at Eurocince Securities AB. Dr. Arwidsson was previously employed as a Chairman by Spago Nanomedical AB, a Chairman by Nanexa AB, a Chief Executive Officer by Biosergen AS, a President, Chief Executive Officer & Director by Eurocine Vaccines AB, a Chief Executive Officer by Lipocore Holding AB, a New Product Manager-Operations by AstraZeneca AB, a Vice President-Business Development by Astra Pharmaceuticals AB, and a Chief Executive Officer by LipoCore AB. He also served on the board at Xspray Pharma AB and Healthy Bizniz Europe AB. He received his graduate degree from the University of Uppsala, an MBA from Stockholm School of Economics and a doctorate degree from the University of Uppsala.
Postes actifs de Hans Arwidsson
| Sociétés | Poste | Début |
|---|---|---|
Eurocince Securities AB
 Eurocince Securities AB Real Estate DevelopmentFinance Engages in management of fixed and movable property | Directeur/Membre du Conseil | - |
Anciens postes connus de Hans Arwidsson
| Sociétés | Poste | Fin |
|---|---|---|
| SPAGO NANOMEDICAL AB | Président | 14/05/2025 |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Directeur Général | 01/01/2007 |
Lipocore Holding AB | Directeur Général | 01/01/2003 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 01/01/2001 |
LipoCore AB | Directeur Général | - |
Formation de Hans Arwidsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Eurocine Vaccines AB
 Eurocine Vaccines AB Pharmaceuticals: MajorHealth Technology Develops nasal influenza vaccines | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astra Pharmaceuticals AB | |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Xspray Pharma AB
 Xspray Pharma AB Pharmaceuticals: MajorHealth Technology Develops and produces particulate materials for the pharmaceutical industry | Health Technology |
LipoCore AB | |
Spago Nanomedical AB
 Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company | Health Technology |
Healthy Bizniz Europe AB | |
Lipocore Holding AB | |
Nanexa AB
 Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company | Health Technology |
Eurocince Securities AB
Eurocince Securities AB Real Estate DevelopmentFinance Engages in management of fixed and movable property | Finance |
